Literature DB >> 27126710

Gastrointestinal tolerance and plasma status of carotenoids, EPA and DHA with a fiber-enriched tube feed in hospitalized patients initiated on tube nutrition: Randomized controlled trial.

L H Jakobsen1, R Wirth2, C Smoliner3, M Klebach4, Z Hofman5, J Kondrup1.   

Abstract

BACKGROUND & AIMS: During the first days of tube feeding (TF) gastrointestinal (GI) complications are common and administration of sufficient nutrition is a challenge. Not all standard nutritionally complete formulas contain dietary fiber, fish oil or carotenoids, key dietary nutrients for health and wellbeing. The aim of this study was to investigate the effects of a fiber, fish oil and carotenoid enriched TF formula on diarrhea, constipation and nutrient bioavailability.
METHODS: A multi-center randomized, double-blind, controlled, parallel trial compared the effects of a dietary fiber, fish oil and carotenoid-enriched TF formula (test) with an isocaloric non-enriched formula (control) in 51 patients requiring initiation of TF. Incidence of diarrhea and constipation (based on stool frequency and consistency) was recorded daily. Plasma status of EPA, DHA and carotenoids was measured after 7 days.
RESULTS: The incidence of diarrhea was lower in patients receiving the test formula compared with the control group (19% vs. 48%, p = 0.034). EPA and DHA status (% of total plasma phospholipids) was higher after 7 days in test compared with control group (EPA: p = 0.002, DHA: p = 0.082). Plasma carotenoid levels were higher after 7 days in the test group compared with control group (lutein: p = 0.024, α-carotene: p = 0.005, lycopene: p = 0.020, β-carotene: p = 0.054).
CONCLUSIONS: This study suggests that the nutrient-enriched TF formula tested might have a positive effect on GI tolerance with less diarrhea incidence and significantly improved EPA, DHA and carotenoid plasma levels during the initiation of TF in hospitalized patients who are at risk of diarrhea and low nutrient status. CLINICAL TRIAL REGISTRATION: This trial was registered at trialregister.nl; registration number 2924.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Carotenoids; Diarrhea; Fiber; Fish oil; Gastrointestinal tolerance; Tube feeding

Mesh:

Substances:

Year:  2016        PMID: 27126710     DOI: 10.1016/j.clnu.2016.02.001

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  5 in total

Review 1.  The effects of dietary fiber on common complications in critically ill patients; with a special focus on viral infections; a systematic reveiw.

Authors:  Azadeh Hajipour; Maryam Afsharfar; Mona Jonoush; Mina Ahmadzadeh; Maryam Gholamalizadeh; Naeemeh Hassanpour Ardekanizadeh; Saeid Doaei; Fatemeh Mohammadi-Nasrabadi
Journal:  Immun Inflamm Dis       Date:  2022-05

2.  High-fibre enteral feeding results in improved anthropometrics and favourable gastrointestinal tolerance in malnourished children with growth failure.

Authors:  Aydan Kansu; Ozlem Durmaz Ugurcan; Duran Arslan; Aycan Unalp; Coskun Celtik; Aysugul Alptekin Sarıoglu
Journal:  Acta Paediatr       Date:  2018-02-21       Impact factor: 2.299

3.  Effect of Shenling Baizhu powder on immunity to diarrheal disease: A systematic review and meta-analysis.

Authors:  Qian Chen; Zheng Xiao; Qing-Ying He; Rui-Rong Zhang; Shu-Xian Chen; Jia-Wei Dong; Hua Zhang; Xiao-Fan Chen
Journal:  Front Pharmacol       Date:  2022-09-14       Impact factor: 5.988

4.  Very high intact-protein formula successfully provides protein intake according to nutritional recommendations in overweight critically ill patients: a double-blind randomized trial.

Authors:  Arthur R H van Zanten; Laurent Petit; Jan De Waele; Hans Kieft; Janneke de Wilde; Peter van Horssen; Marianne Klebach; Zandrie Hofman
Journal:  Crit Care       Date:  2018-06-12       Impact factor: 9.097

5.  Stool pattern is associated with not only the prevalence of tumorigenic bacteria isolated from fecal matter but also plasma and fecal fatty acids in healthy Japanese adults.

Authors:  Daiki Watanabe; Haruka Murakami; Harumi Ohno; Kumpei Tanisawa; Kana Konishi; Kikue Todoroki-Mori; Yuta Tsunematsu; Michio Sato; Yuji Ogata; Noriyuki Miyoshi; Naoto Kubota; Jun Kunisawa; Keiji Wakabayashi; Tetsuya Kubota; Kenji Watanabe; Motohiko Miyachi
Journal:  BMC Microbiol       Date:  2021-06-28       Impact factor: 3.605

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.